Daniele Farci
University of Cagliari(IT)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Adipokines, Inflammation, and Metabolic Diseases, Frailty in Older Adults
Most-Cited Works
- → Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy(2017)63 cited
- → Interleukin‐6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients(2008)46 cited
- → Results of Whole Brain Radiation Therapy in Patients with Brain Metastases from Colorectal Carcinoma(2005)28 cited
- → A review of immune checkpoint blockade in breast cancer(2021)17 cited
- → An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience(2019)16 cited
- Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.(2007)
- → Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM)(2019)4 cited
- → Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors(2024)1 cited
- → A narrative review of the principal glucocorticoids employed in cancer(2022)1 cited
- → Defining the role and competencies of the medical oncologist in diagnostic and therapeutic care pathways: Consensus recommendations from the Italian association of medical oncology (AIOM)(2026)